Sensus Healthcare, which sells low-energy x-ray systems for treating non-melanoma skin cancer and keloids, announced terms for its IPO on Friday.
The Boca Raton, FL-based company plans to raise $11 million by offering 1.8 million units at a price of $6.25, consisting of one common share and one warrant. At the midpoint of the proposed range, Sensus Healthcare would command a fully diluted market value of $80 million.
Sensus Healthcare was founded in 2010 and booked $10 million in sales for the 12 months ended December 31, 2015. It plans to list on the Nasdaq under the symbol SRTSU. Northland Securities (added on the update) and Neidiger, Tucker, Bruner are the joint bookrunners on the deal. Pricing information was not disclosed.
